Free Trial

Compass Therapeutics (CMPX) SEC Filings & 10K Form

Compass Therapeutics logo
$2.06 -0.04 (-1.90%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$2.08 +0.02 (+0.92%)
As of 05/21/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Compass Therapeutics SEC Filings

DateFilerForm TypeView
05/08/2025
7:00 AM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:01 AM
Compass Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2025
12:27 PM
Compass Therapeutics (Filer)
Form DEFA14A
04/29/2025
7:30 AM
Compass Therapeutics (Filer)
Form DEF 14A
04/29/2025
7:30 AM
Compass Therapeutics (Filer)
Form ARS
04/11/2025
6:37 PM
Compass Therapeutics (Issuer)
GORDON CARL L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
6:21 PM
Compass Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SCHEDULE 13D/A
04/11/2025
6:24 PM
Compass Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
5:51 PM
Compass Therapeutics (Subject)
ORBIMED CAPITAL LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/09/2025
5:58 PM
Compass Therapeutics (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2025
8:25 AM
Compass Therapeutics (Issuer)
Lerner Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
8:30 AM
Anderman Jonathan (Reporting)
Compass Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
6:00 AM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
5:39 AM
Compass Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
7:30 AM
Compass Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
7:00 AM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
4:10 PM
Compass Therapeutics (Issuer)
GRAY MARY ANN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:11 PM
Compass Therapeutics (Issuer)
Lerner Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:11 PM
Compass Therapeutics (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:12 PM
Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:12 PM
Compass Therapeutics (Issuer)
Shin Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:05 PM
Boylan James P (Reporting)
Compass Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:08 PM
Compass Therapeutics (Issuer)
GORDON CARL L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:09 PM
Anderman Jonathan (Reporting)
Compass Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:09 PM
Chiniara Ellen (Reporting)
Compass Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:39 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Compass Therapeutics (Subject)
Form SCHEDULE 13G/A
02/11/2025
9:37 AM
Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
4:17 PM
Compass Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/13/2025
7:30 AM
Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:00 AM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
1:00 PM
Compass Therapeutics (Issuer)
Lerner Neil (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/10/2024
1:01 PM
Compass Therapeutics (Issuer)
Shin Barry (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/10/2024
1:02 PM
Compass Therapeutics (Issuer)
Shin Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
7:00 AM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
9:00 AM
Compass Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
09/08/2024
11:15 PM
Compass Therapeutics (Filer)
Form EFFECT
08/30/2024
4:23 PM
Compass Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/14/2024
7:49 AM
Anderman Jonathan (Reporting)
Compass Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
7:00 AM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:00 AM
Compass Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/17/2024
7:32 AM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Warning: Prepare to Be Shocked by These Payouts (Ad)

There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.

Click here to see how much you could be collecting each month →
05/28/2024
3:09 PM
Compass Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CMPX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners